Table 4.
Interaction between faces displaying direct and averted gaze in the placebo and oxytocin group [(CSdg+ vs CSdg−) vs (CSag+ vs CSag−)]
Placebo group |
Oxytocin group |
Difference placebo > oxytocin group |
|||||||
---|---|---|---|---|---|---|---|---|---|
Coordinates | t value | p value | Coordinates | t value | p value | Coordinates | t value | p value | |
Amy | 20, 0, −20 | 3.94 | <0.05* | 20, 0, −20 | 3.55 | <0.05* | |||
Amy | −18, −8, −26 | 2.56 | NS | ||||||
R Insula | 30, 30, −10 | 3.66 | <0.001 | ||||||
R FFA | 42, −50, −14 | −4.58 | <0.001 | 42, −50, −14 | 3.59 | <0.001 | |||
cACC | 14, 0, 40 | 3.89 | <0.001 | ||||||
−12, −2, 48 | 4.04 | <0.001 | |||||||
mObfc | 16, 44, −18 | 3.89 | <0.001 | ||||||
rACC/vmPFC | 4, 62, 0 | −5.60 | <0.001 | 4, 62, 0 | 4.16 | <0.001 | |||
vlPFC | 34, 62, 4 | 3.73 | <0.001 | ||||||
vlPFC | 46, 50, 4 | 4.37 | <0.001 |
Amy, Amygdala; FFA, fusiform face area; cACC, caudal anterior cingulate cortex; mObfc, medial orbitofrontal cortex; rACC, rostral anterior cingulate cortex; vmPFC, ventromedial prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; R, right; NS, nonsignificant. *Small volume corrected.